Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Redox Biology|April 3, 2026
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus familiesAlice Pedersen, Julia Blay-Cadanet, Jacob Storgaard, et al.
Plos Pathogens|May 2, 2013
Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityMarie-Line Goulet, David Olagnier, Zhengyun Xu, et al.
The Journal of Biological Chemistry|April 26, 2023
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral developmentStephen Boulton, Mathieu J F Crupi, Siddharth Singh, et al.
Angewandte Chemie (International Ed. in English)|August 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein InteractionChunyu Lin, Dilip Narayanan, Marilia Barreca, et al.
Science Signaling|November 29, 2022
VPS34-dependent control of apical membrane function of proximal tubule cells and nutrient recovery by the kidneyMarkus M Rinschen, Jennifer L Harder, Madalina E Carter-Timofte, et al.
Communications Biology|March 7, 2024
SAM68 directs STING signaling to apoptosis in macrophagesDemi van der Horst, Naziia Kurmasheva, Mikkel H S Marqvorsen, et al.
Science Immunology|December 14, 2020
Defects in <i>LC3B2</i> and <i>ATG4A</i> underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humansAlon Schneider Hait, David Olagnier, Vanessa Sancho-Shimizu, et al.
The EMBO Journal|February 18, 2022
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infectionRenée M van der Sluis, Lamin B Cham, Albert Gris-Oliver, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signalingAnne Louise Hansen, Gregory J Buchan, Michael Rühl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
Pageof 9